Skip to main content
SpringerLink
Log in
Book cover

Encyclopedia of AIDS pp 1–8Cite as

Medication Adherence and HIV-Associated Neurocognitive Disorders (HAND)

  • Living reference work entry
  • First Online:

  • 40 Accesses

Definition/Introduction

Among persons living with HIV infection, adherence to antiretroviral therapy (ART) and other prescribed medications is the critical factor associated with reductions in morbidity and mortality. As a result, HIV is often considered a chronic illness. There have been several advancements in ART medication development, formulation, and administration that have increased the ease of ART adherence as compared to the early years of the epidemic. Specifically, side effect profiles have improved medication tolerability, and there are newer combination medications that allow for most regimens to be between one to three pills per day. Along with the view that HIV has become a chronic illness, however, is the observation that the number of chronic comorbidities among those with HIV has grown. Thus, pill burden remains high among HIV-infected persons as compared to the general population, although many of the medications are for the treatment of HIV-related conditions...

This is a preview of subscription content, log in via an institution.

References

  • Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Ellis RJ, Grant I, Woods SP. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013a;7(4):255–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blackstone K, Woods SP, Weber E, Grant I, Moore DJ, the HNRC Group. Memory-based adherence strategies for antiretroviral medication management in HIV: an evaluation of clinical predictors, adherence behavior awareness, and effectiveness. AIDS Behav. 2013b;17(1):74–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crum-Cianflone NF, Moore DJ, Letendre S, Roediger MP, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013;80(4):371–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19(2):169–85.

    Article  PubMed  Google Scholar 

  • Ettenhofer ML, Foley J, Castellon SA, Hinkin CH. Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology. 2010;74(15):1217–22.

    Article  PubMed  PubMed Central  Google Scholar 

  • Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One. 2014;9(2):e88166.

    Article  PubMed  PubMed Central  Google Scholar 

  • Genberg BL, Wilson IB, Bangsberg DR, Arnsten J, Goggin K, Remien RH, Simoni J, Gross R, Reynolds N, Rosen M, Liu H. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS. 2012;26(11):1415–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heaton RK, Clifford DB, Franklin Jr DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010;75(23):2087–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.

    Article  CAS  PubMed  Google Scholar 

  • Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19–25.

    Article  PubMed  PubMed Central  Google Scholar 

  • Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, et al. Lithium improves HIV associated neurocognitive impairment. AIDS. 2006;20(14):1885–8.

    Article  CAS  PubMed  Google Scholar 

  • Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.

    Article  PubMed  Google Scholar 

  • Poquette AJ, Moore DJ, Gouaux B, Morgan EE, Grant I, Woods SP. Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test. J Int Neuropsychol Soc. 2013;19(2):155–61.

    Article  PubMed  Google Scholar 

  • Winston A, Vera JH. Can antiretroviral therapy prevent HIV-associated cognitive disorders? Curr Opin HIV AIDS. 2014;9(1):11–6.

    Article  CAS  PubMed  Google Scholar 

  • Woods SP, Dawson MS, Weber E, Gibson S, Grant I, Atkinson JH. Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc. 2009;15(1):42–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of California, San Diego, San Diego, CA, USA

    David J. Moore

  2. SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, CA, USA

    Jessica L. Montoya & Kaitlin B. Casaletto

  3. VA San Diego Healthcare System & Department of Psychiatry, University of California, San Diego, San Diego, CA, USA

    J. Hampton Atkinson

Authors
  1. David J. Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica L. Montoya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kaitlin B. Casaletto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Hampton Atkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Moore .

Editor information

Editors and Affiliations

  1. Dept. Cell & Molecular Biology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA

    Thomas J. Hope

  2. University of California, San Diego Dept. Pathology, La Jolla, California, USA

    Douglas Richman

  3. Office of Graduate and Postdoctoral Studies, University of Miami, Miller School of Medicine, Miami, Florida, USA

    Mario Stevenson

Section Editor information

  1. University of Pennsylvania, 415 Curie Blvd.; 280C Clinical Research Building, 19104/6146, Philadelphia, PA, USA

    Dennis L Kolson

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this entry

Cite this entry

Moore, D.J., Montoya, J.L., Casaletto, K.B., Hampton Atkinson, J. (2017). Medication Adherence and HIV-Associated Neurocognitive Disorders (HAND). In: Hope, T., Richman, D., Stevenson, M. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_466-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_466-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9610-6

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation